Medtronic Appoints CFO Ahead of Diabetes Unit Spin-Off
Medtronic Appoints CFO Ahead of Diabetes Unit Spin-Off

Medtronic Appoints CFO Ahead of Diabetes Unit Spin-Off

News summary

Medtronic has appointed Chad Spooner as CFO of MiniMed, the diabetes division set to become a standalone public company within 18 months. This move is part of Medtronic's plan to separate its diabetes business to create a more focused portfolio, enhancing shareholder value and accelerating profitable growth. Spooner brings over 25 years of financial leadership experience, including roles as CFO at BIC and senior positions at General Electric. MiniMed, led by CEO Que Dallara, aims to innovate diabetes care for type 1 and type 2 patients, focusing on simplifying insulin management. The separation is expected to be accretive to Medtronic's earnings and operating margin, with a generally tax-free transition for shareholders. Medtronic's strong recent financial performance, including a 7% stock price increase and a dividend hike, underscores investor confidence amid broader market uncertainties.

Story Coverage
Bias Distribution
100% Left
Information Sources
daae85f0-2883-42fc-b085-888140adf30d
Left 100%
Coverage Details
Total News Sources
1
Left
1
Center
0
Right
0
Unrated
0
Last Updated
12 hours ago
Bias Distribution
100% Left
Related News
Daily Index

Negative

26Serious

Neutral

Optimistic

Positive

Ask VT AI
Story Coverage
Subscribe

Stay in the know

Get the latest news, exclusive insights, and curated content delivered straight to your inbox.

Present

Gift Subscriptions

The perfect gift for understanding
news from all angles.

Related News
Recommended News